Borderline ovarian tumors and fertility

Current Opinion in Obstetrics and Gynecology

Volumn 22, Issue 3, 2010, Pages 227-234

  Nam, Joo Hyun ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Borderline ovarian tumor; Fertility; Fertility sparing surgery

Indexed keywords

ESTROGEN; GONADOTROPIN DERIVATIVE;

BILATERAL CANCER; BORDERLINE OVARY TUMOR; CANCER INVASION; CANCER SCREENING; CLINICAL TRIAL; CRYOPRESERVATION; ECTOPIC PREGNANCY; FEMALE FERTILITY; FERTILITY SPARING SURGERY; FETUS MALFORMATION; GYNECOLOGIC SURGERY; HUMAN; LAPAROSCOPY; LAPAROTOMY; OVARIAN PRESERVATION; OVARIECTOMY; OVARY CANCER; OVARY TUMOR; OVULATION INDUCTION; PREGNANCY OUTCOME; PREGNANCY RATE; PREMATURE LABOR; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SALPINGOOOPHORECTOMY; SURGICAL APPROACH; SURGICAL TECHNIQUE; TUMOR RECURRENCE;

BIOPSY; FALLOPIAN TUBES; FEMALE; HUMANS; INFERTILITY, FEMALE; LAPAROSCOPY; NEOPLASM INVASIVENESS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; OVARIECTOMY; OVARY; PERITONEAL NEOPLASMS; PREGNANCY;

EID: 77951937628     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/GCO.0b013e3283384928     Document Type: Review

References (69)

1. Classification and staging of malignant tumours in the female pelvis. Acta Obstet Gynecol Scand 1971; 50: 1-7.
2. Serov SF, Scully RE, Sobin LH. The World Health Organization International Histological Classification of Ovarian Tumors: histological typing of ovarian tumors. Geneva, Switzerland: World Health Organization; 1973. pp. 37-38.
3. Scully RE. World Health Organization classification and nomenclature of ovarian cancer. Natl Cancer Inst Monogr 1975; 42: 5-7.
4. Acs G. Serous and mucinous borderline (low malignant potential) tumors of the ovary. Am J Clin Pathol 2005; 123 (Suppl) : S13-S57.
5. Tinelli R, Tinelli A, Tinelli FG, et al. Conservative surgery for borderline ovarian tumors: a review. Gynecol Oncol 2006; 100: 185-191.
6. Ozols RF, Rubin SC, Thomas GM, et al. Epithelial ovarian cancer. In: Hoskins WJ, Perez CA, Young RC, editors. Principle and practice of gynecologic oncology, 4th ed. Philadelphia, Pennsylvania, USA: Lippincott Williams & Wilkins; 2005. pp. 895-987.
7. Cadron I, Leunen K, Van Gorp T, et al. Management of borderline ovarian neoplasms. J Clin Oncol 2007; 25: 2928-2937.
8. Seidman JD, Kurman RJ. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol 2000; 31: 539-557.
9. Camatte S, Morice P, Thoury A, et al. Impact of surgical staging in patients with macroscopic 'stage I' ovarian borderline tumours: analysis of a continuous series of 101 cases. Eur J Cancer 2004; 40: 1842-1849.
10. Desfeux P, Camatte S, Chatellier G, et al. Impact of surgical approach on the management of macroscopic early ovarian borderline tumors. Gynecol Oncol 2005; 98: 390-395.
11. Cho YH, Kim DY, Kim JH, et al. Is complete surgical staging necessary in patients with stage I mucinous epithelial ovarian tumors? Gynecol Oncol 2006; 103: 878-882.
12. Ji H, Yliskoski M, Anttila M, et al. Management of stage-I borderline ovarian tumors. Int J Gynaecol Obstet 1996; 54: 37-44.
13. Gotlieb WH, Flikker S, Davidson B, et al. Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome. Cancer 1998; 82: 141-146.
14. Zanetta G, Rota S, Chiari S, et al. Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study. J Clin Oncol 2001; 19: 2658-2664.
15. Morice P, Camatte S, El Hassan J, et al. Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors. Fertil Steril 2001; 75: 92-96.
16. Romagnolo C, Gadducci A, Sartori E, et al. Management of borderline ovarian tumors: results of an Italian multicenter study. Gynecol Oncol 2006; 101: 255-260.
17. Donnez J, Munschke A, Berliere M, et al. Safety of conservative management and fertility outcome in women with borderline tumors of the ovary. Fertil Steril 2003; 79: 1216-1221.
18. Fauvet R, Boccara J, Dufournet C, et al. Laparoscopic management of borderline ovarian tumors: results of a French multicenter study. Ann Oncol 2005; 16: 403-410. (Pubitemid 40458316)
19. Park JY, Kim DY, Kim JH, et al. Surgical management of borderline ovarian •• tumors: the role of fertility-sparing surgery. Gynecol Oncol 2009; 113: 75-82. This is one of the largest studies that compared the oncologic outcomes between radical surgery group and fertility-sparing surgery group and presented the reproductive outcomes of fertility-sparing surgery group.
20. De Iaco P, Ferrero A, Rosati F, et al. Behaviour of ovarian tumors of low • malignant potential treated with conservative surgery. Eur J Surg Oncol 2009; 35: 643-648. This study compared the oncologic outcomes between radical surgery group and fertility-sparing surgery group and presented the reproductive outcomes of fertilitysparing surgery group.
21. Cheng B, Wan X, Qian X, et al. Results of conservative surgery for recurrent • borderline ovarian tumors. Eur J Gynaecol Oncol 2009; 30: 75-78. This study evaluated the oncologic and reproductive outcomes after second-round fertility-sparing surgery for women with recurrent BOT after fertility-sparing surgery.
22. Prat J, De Nictolis M. Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion. Am J Surg Pathol 2002; 26: 1111-1128.
23. Camatte S, Morice P, Pautier P, et al. Fertility results after conservative treatment of advanced stage serous borderline tumour of the ovary. BJOG 2002; 109: 376-380.
24. Longacre TA, McKenney JK, Tazelaar HD, et al. Ovarian serous tumors of low malignant potential (borderline tumors) : outcome-based study of 276 patients with long-term (> or = 5-year) follow-up. Am J Surg Pathol 2005; 29: 707-723.
25. Vigano R, Petrone M, Pella F, et al. Surgery in advanced borderline tumors. • Fertil Steril 2009. [Epub ahead of print] This is a retrospective study, which evaluated the oncologic and reproductive outcomes of fertility-sparing surgery in patients with advanced-stage BOTs.
26. Uzan C, Kane A, Rey A, et al. Outcomes after conservative treatment of •• advanced-stage serous borderline tumors of the ovary. Ann Oncol 2010; 21: 55-60. This is the largest series, which evaluated the oncologic and reproductive outcomes of fertility-sparing surgery in patients with advanced-stage BOT.
27. Gershenson DM, Silva EG, Tortolero-Luna G, et al. Serous borderline tumors of the ovary with noninvasive peritoneal implants. Cancer 1998; 83: 2157-2163.
28. Gershenson DM, Silva EG, Levy L, et al. Ovarian serous borderline tumors with invasive peritoneal implants. Cancer 1998; 82: 1096-1103.
29. Kane A, Uzan C, Rey A, et al. Prognostic factors in patients with ovarian serous • low malignant potential (borderline) tumors with peritoneal implants. Oncologist 2009; 14: 591-600. This is a large series, which evaluated the prognostic factors in 168 patients who had BOT with extraovarian implants.
30. Burks RT, Sherman ME, Kurman RJ. Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Pathol 1996; 20: 1319-1330.
31. Seidman JD, Kurman RJ. Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases. Am J Surg Pathol 1996; 20: 1331-1345.
32. Deavers MT, Gershenson DM, Tortolero-Luna G, et al. Micropapillary and cribriform patterns in ovarian serous tumors of low malignant potential: a study of 99 advanced stage cases. Am J Surg Pathol 2002; 26: 1129-1141.
33. Chang SJ, Ryu HS, Chang KH, et al. Prognostic significance of the micro-• papillary pattern in patients with serous borderline ovarian tumors. Acta Obstet Gynecol Scand 2008; 87: 476-481. In this study, the presence of micropapillary pattern was significant prognostic factor in patients with BOT.
34. Slomovitz BM, Caputo TA, Gretz HF 3rd, et al. A comparative analysis of 57 serous borderline tumors with and without a noninvasive micropapillary component. Am J Surg Pathol 2002; 26: 592-600.
35. Winter WE 3rd, Kucera PR, Rodgers W, et al. Surgical staging in patients with ovarian tumors of low malignant potential. Obstet Gynecol 2002; 100: 671-676.
36. Laurent I, Uzan C, Gouy S, et al. Results after conservative treatment of serous • borderline tumors of the ovary with a micropapillary pattern. Ann Surg Oncol 2008; 15: 3561-3566. This study included 15 patients with micropapillary BOT who underwent fertilitysparing surgery.
37. Kennedy AW, Hart WR. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long-term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma. Cancer 1996; 78: 278-286.
38. Ren J, Peng Z, Yang K. A clinicopathologic multivariate analysis affecting • recurrence of borderline ovarian tumors. Gynecol Oncol 2008; 110: 162-167. In multivariate analysis including 234 patients with BOT, surgical procedure, cyst rupture, stage of disease, microinvasion, and peritoneal implants were independent prognostic factors for disease-free survival.
39. Laurent I, Uzan C, Gouy S, et al. Results after conservative treatment of serous • borderline tumours of the ovary with stromal microinvasion but without micropapillary pattern. BJOG 2009; 116: 860-862. This study included 18 patients who underwent fertility-sparing surgery for BOT with stromal microinvasion but without micropapillary pattern.
40. Weinstein D, Polishuk WZ. The role of wedge resection of the ovary as a cause for mechanical sterility. Surg Gynecol Obstet 1975; 141: 417-418.
41. ParkJY, Bae J, Lim MC, et al. Laparoscopic and laparotomic staging in stage I epithelial ovarian cancer: a comparison of feasibility and safety. Int J Gynecol Cancer 2008; 18: 1202-1209.
42. ParkJY, Kim DY, Suh DS, et al. Comparison of laparoscopy and laparotomy in surgical staging of early-stage ovarian and fallopian tubal cancer. Ann Surg Oncol 2008; 15: 2012-2019.
43. Maneo A, Vignali M, Chiari S, et al. Are borderline tumors of the ovary safely treated by laparoscopy? Gynecol Oncol 2004; 94: 387-392.
44. Boran N, Cil AP, Tulunay G, et al. Fertility and recurrence results of conservative surgery for borderline ovarian tumors. Gynecol Oncol 2005; 97: 845-851.
45. Tinelli R, Malzoni M, Cosentino F, et al. Feasibility, safety, and efficacy of • conservative laparoscopic treatment of borderline ovarian tumors. Fertil Steril 2009; 92: 736-741. This is a comprehensive review on the role of laparoscopic surgery in fertilitysparing management for young women with BOT.
46. Papadimitriou DS, Martin-Hirsch P, Kitchener HC, et al. Recurrent borderline ovarian tumours after conservative management in women wishing to retain their fertility. Eur J Gynaecol Oncol 1999; 20: 94-97.
47. Morris RT, Gershenson DM, Silva EG, et al. Outcome and reproductive function after conservative surgery for borderline ovarian tumors. Obstet Gynecol 2000; 95: 541-547.
48. Seracchioli R, Venturoli S, Colombo FM, et al. Fertility and tumor recurrence rate after conservative laparoscopic management of young women with earlystage borderline ovarian tumors. Fertil Steril 2001; 76: 999-1004.
49. Demeter A, Csapo Z, Szantho A, et al. A retrospective study of 27 ovarian tumors of low malignant potential. Eur J Gynaecol Oncol 2002; 23: 415-418.
50. Chan JK, Lin YG, Loizzi V, et al. Borderline ovarian tumors in reproductive-age women. Fertility-sparing surgery and outcome. J Reprod Med 2003; 48: 756-760.
51. Rao GG, Skinner EN, Gehrig PA, et al. Fertility-sparing surgery for ovarian low malignant potential tumors. Gynecol Oncol 2005; 98: 263-266.
52. Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 1992; 136: 1184-1203. (Pubitemid 23026890)
53. Rossing MA, Daling JR, Weiss NS, et al. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994; 331: 771-776.
54. Zheng W, Lu JJ, Luo F, et al. Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone. Gynecol Oncol 2000; 76: 80-88. (Pubitemid 30048324)
55. Tourgeman DE, Lu JJ, Boostanfar R, et al. Human chorionic gonadotropin suppresses ovarian epithelial neoplastic cell proliferation in vitro. Fertil Steril 2002; 78: 1096-1099. (Pubitemid 35292515)
56. Fortin A, Morice P, Thoury A, et al. Impact of infertility drugs after treatment of borderline ovarian tumors: results of a retrospective multicenter study. Fertil Steril 2007; 87: 591-596. (Pubitemid 46385955)
57. Attar E, Berkman S, Topuz S, et al. Evolutive peritoneal disease after conservative management and the use of infertility drugs in a patient with stage IIIC borderline micro-papillary serous carcinoma (MPSC) of the ovary: case report. Hum Reprod 2004; 19: 1472-1475. (Pubitemid 38807726)
58. Fauvet R, Poncelet C, Boccara J, et al. Fertility after conservative treatment for borderline ovarian tumors: a French multicenter study. Fertil Steril 2005; 83: 284-290; (Pubitemid 40221778)
59. quiz 525-526.
60. Abusief ME, Hornstein MD, Jain T. Assessment of United States fertility clinic websites according to the American Society for Reproductive Medicine (ASRM)/Society for Assisted Reproductive Technology (SART) guidelines. Fertil Steril 2007; 87: 88-92. (Pubitemid 46013874)
61. Gallot D, Pouly JL, Janny L, et al. Successful transfer of frozen-thawed embryos obtained immediately before radical surgery for stage IIIa serous borderline ovarian tumour: case report. Hum Reprod 2000; 15: 2347-2350.
62. Oktay K, Cil AP, Bang H. Efficiency of oocyte cryopreservation: a metaanalysis. Fertil Steril 2006; 86: 70-80.
63. Donnez J, Dolmans MM, Demylle D, et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 2004; 364: 1405-1410. (Pubitemid 39370715)
64. Meirow D, Levron J, Eldar-Geva T, et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med 2005; 353: 318-321. (Pubitemid 41058339)
65. Demeestere I, Simon P, Buxant F, et al. Ovarian function and spontaneous pregnancy after combined heterotopic and orthotopic cryopreserved ovarian tissue transplantation in a patient previously treated with bone marrow transplantation: case report. Hum Reprod 2006; 21: 2010-2014. (Pubitemid 44288074)
66. Kim SS, Radford J, Harris M, et al. Ovarian tissue harvested from lymphoma patients to preserve fertility may be safe for autotransplantation. Hum Reprod 2001; 16: 2056-2060. (Pubitemid 32951894)
67. Fain-Kahn V, Poirot C, Uzan C, et al. Feasibility of ovarian cryopreservation in •• borderline ovarian tumours. Hum Reprod 2009; 24: 850-855. This study included 15 patients with micropapillary BOT who underwent fertilitysparing surgery. This is a retrospective study, which evaluated the feasibility of ovarian cryopreservation in 23 patients treated for BOT.
68. Navot D, Fox JH, Williams M, et al. The concept of uterine preservation with ovarian malignancies. Obstet Gynecol 1991; 78: 566-568.
69. Lawal AH, B-Lynch C. Borderline ovarian cancer, bilateral surgical castration, chemotherapy and a normal delivery after ovum donation and in vitro fertilisation-embryo transfer. Br J Obstet Gynaecol 1996; 103: 931-932.